A recent study suggests that sleeve lobectomy is safe to perform in patients with non–small cell lung cancer who received neoadjuvant therapy. In patients with non­–small-cell lung cancer (NSCLC) who ...

[Singapore, 10:05 a.m. SGT--September 11, 2023] – Adding perioperative durvalumab to neoadjuvant chemotherapy did not adversely impact surgery in patients with resectable NSCLC and was associated with ...

The lungs are a pair of spongy organs in your chest. The right lung is bigger than the left lung. Each lung is divided into smaller parts called lobes. The right lung has three lobes, and the left ...

Lung cancer is a common and serious type of cancer that is considered to be the most common type of cancer to affect people worldwide. In fact, at the end of 2018, about 2.1 million new cases of lung ...

Studies have reported an association between hospital volume and survival for non–small-cell lung cancer (NSCLC). We explored this association in England, accounting for case mix and propensity to ...

Pulmonary resection is the first line of treatment of stage I and II non-small cell lung cancer (NSCLC). It is also important as part of the management of stage IIIA. In early stages of NSCLC, the ...

Please provide your email address to receive an email when new articles are posted on . “We believe that these results are quite powerful and informative,” Christopher Seder, MD, thoracic surgeon at ...

Lung cancer is the number one cancer killer of both men and women, but new surgical options are making a difference. Treatment for lung cancer used to mean major surgery. Doctors would have to crack a ...

The operative modes for pulmonary parenchymal resection include pneumonectomy, bilobectomy, lobectomy, segmentectomy, and wedge resection, according to the volume of lung parenchyma to be resected.

SEGMENTAL pulmonary resection for bronchiectasis is based on the concept that it is most advantageous to conserve all healthy tissue and limit resection to the specific pulmonary segments destroyed by ...